JP2019187264A - 糖代謝異常の予防および改善用組成物 - Google Patents
糖代謝異常の予防および改善用組成物 Download PDFInfo
- Publication number
- JP2019187264A JP2019187264A JP2018082025A JP2018082025A JP2019187264A JP 2019187264 A JP2019187264 A JP 2019187264A JP 2018082025 A JP2018082025 A JP 2018082025A JP 2018082025 A JP2018082025 A JP 2018082025A JP 2019187264 A JP2019187264 A JP 2019187264A
- Authority
- JP
- Japan
- Prior art keywords
- present
- lactic acid
- composition
- abnormal
- acid bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 230000002159 abnormal effect Effects 0.000 title claims abstract description 38
- 230000002265 prevention Effects 0.000 title abstract description 8
- 230000006872 improvement Effects 0.000 title abstract description 7
- 241000186605 Lactobacillus paracasei Species 0.000 claims abstract description 35
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims abstract description 19
- 201000001421 hyperglycemia Diseases 0.000 claims abstract description 16
- 206010022489 Insulin Resistance Diseases 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 14
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 59
- 239000008103 glucose Substances 0.000 claims description 59
- 239000008280 blood Substances 0.000 claims description 55
- 210000004369 blood Anatomy 0.000 claims description 55
- 235000013305 food Nutrition 0.000 claims description 32
- 230000004060 metabolic process Effects 0.000 claims description 25
- 108010034143 Inflammasomes Proteins 0.000 claims description 21
- 230000004153 glucose metabolism Effects 0.000 claims description 18
- 230000004913 activation Effects 0.000 claims description 13
- 230000005856 abnormality Effects 0.000 claims description 9
- 230000003345 hyperglycaemic effect Effects 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 158
- 241000894006 Bacteria Species 0.000 description 81
- 235000014655 lactic acid Nutrition 0.000 description 79
- 239000004310 lactic acid Substances 0.000 description 79
- 235000009200 high fat diet Nutrition 0.000 description 25
- 239000003795 chemical substances by application Substances 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 21
- 239000000047 product Substances 0.000 description 21
- 238000012360 testing method Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 244000269722 Thea sinensis Species 0.000 description 17
- 235000013616 tea Nutrition 0.000 description 16
- 208000008589 Obesity Diseases 0.000 description 15
- 235000005911 diet Nutrition 0.000 description 15
- 235000020824 obesity Nutrition 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 14
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 12
- 239000002158 endotoxin Substances 0.000 description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 229920006008 lipopolysaccharide Polymers 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 230000037213 diet Effects 0.000 description 10
- 238000007446 glucose tolerance test Methods 0.000 description 10
- 230000002757 inflammatory effect Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 235000000891 standard diet Nutrition 0.000 description 9
- 102000004127 Cytokines Human genes 0.000 description 8
- 108090000695 Cytokines Proteins 0.000 description 8
- 241000282412 Homo Species 0.000 description 8
- 230000037396 body weight Effects 0.000 description 8
- 210000004979 bone marrow derived macrophage Anatomy 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- 238000012353 t test Methods 0.000 description 7
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 6
- 230000037406 food intake Effects 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 241000282414 Homo sapiens Species 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 230000000378 dietary effect Effects 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 235000015192 vegetable juice Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108090000426 Caspase-1 Proteins 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 210000002798 bone marrow cell Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 201000009104 prediabetes syndrome Diseases 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 208000036487 Arthropathies Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 108090000171 Interleukin-18 Proteins 0.000 description 2
- 102000003810 Interleukin-18 Human genes 0.000 description 2
- 208000012659 Joint disease Diseases 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000016396 cytokine production Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 235000015897 energy drink Nutrition 0.000 description 2
- 235000019225 fermented tea Nutrition 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000015788 innate immune response Effects 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 235000021056 liquid food Nutrition 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000019992 sake Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 240000006914 Aspalathus linearis Species 0.000 description 1
- 235000012984 Aspalathus linearis Nutrition 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 208000022715 Autoinflammatory syndrome Diseases 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 102100035904 Caspase-1 Human genes 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 244000207620 Euterpe oleracea Species 0.000 description 1
- 235000012601 Euterpe oleracea Nutrition 0.000 description 1
- 206010016207 Familial Mediterranean fever Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108090000193 Interleukin-1 beta Proteins 0.000 description 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 101001033286 Mus musculus Interleukin-1 beta Proteins 0.000 description 1
- 101000960949 Mus musculus Interleukin-18 Proteins 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 102000012064 NLR Proteins Human genes 0.000 description 1
- 108091005686 NOD-like receptors Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 102000005583 Pyrin Human genes 0.000 description 1
- 108010059278 Pyrin Proteins 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000003650 acai Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000031037 interleukin-18 production Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000020094 liqueur Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000013227 male C57BL/6J mice Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000013586 microbial product Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- -1 rice Chemical class 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000020330 rooibos tea Nutrition 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000020083 shōchū Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Images
Abstract
Description
[1]ラクトバチルス・パラカゼイ菌体および/またはその処理物を有効成分として含んでなる、糖代謝異常の予防または改善用組成物および糖代謝異常の予防または改善剤。
[2]糖代謝異常が、空腹時高血糖、随時高血糖および食後高血糖からなる群から選択される高血糖状態である、上記[1]に記載の組成物および用剤。
[3]糖代謝異常が、耐糖能異常である、上記[1]に記載の組成物および用剤。
[4]糖代謝異常が、インスリン抵抗性である、上記[1]に記載の組成物および用剤。
[5]糖代謝異常が、インフラマソームの活性化に起因するものである、上記[1]〜[4]のいずれかに記載の組成物および用剤。
[6]ラクトバチルス・パラカゼイ菌体および/またはその処理物を有効成分として含んでなる、血糖値上昇の抑制用組成物および血糖値上昇抑制剤。
[7]ラクトバチルス・パラカゼイ菌体および/またはその処理物を有効成分として含んでなる、インフラマソームの活性化抑制用組成物およびインフラマソームの活性化抑制剤。
[8]食品組成物である、上記[1]〜[7]のいずれかに記載の組成物および用剤。
[9]ラクトバチルス・パラカゼイが、KW3110菌株(FERM BP−08634)である、上記[1]〜[8]のいずれかに記載の組成物および用剤。
・血糖値の気になる方に
・血糖値が高めの方に
・血糖値上昇が気になる方に
(1)試験方法
6〜8週齢の雌性C57BL/6Jマウス1匹(チャールズリバー社)から骨髄細胞(BM)を回収し、RPMI 1640培地(SIGMA社製)にて骨髄細胞を5×105細胞/mLに調製後、骨髄由来マクロファージ(BMM)を分化させるために最終濃度100ng/mLのマクロファージコロニー刺激因子(R&D社製、本明細書において「M−CSF」ということがある)を添加し、6日間培養した。6日後に骨髄由来マクロファージを回収して洗浄した後、1×106細胞/mLに調製した骨髄由来マクロファージを24wellプレートに1mLずつ播種した。これを6群分で3セット用意した。具体的には、試験群としてラクトバシラス・パラカゼイ・KW3110株(本明細書において、「KW」または「KW乳酸菌」ということがある)を添加する群を「KW群」とし、対照乳酸菌としてラクトバチルス・ラムノーサス・GG株(ATCC53103、アメリカン・タイプ・カルチャー・コレクションから入手)(本明細書において、「LGG」または「LGG乳酸菌」ということがある)を添加する群を「LGG群」とし、いずれの乳酸菌も添加しない群を「対照群1〜4」とした。KW群およびLGG群には、KW3110株またはLGGの加熱死菌体を最終濃度10μg/mLで添加し24時間培養した。24時間培養後に最終濃度10ng/mLのリポ多糖(InvivoGen社製、本明細書において「LPS」ということがある)を添加し、LPS添加から4時間後に最終濃度2mMのアデノシン三リン酸(Sigma社製、本明細書において「ATP」ということがある)を添加した。なお、対照群1にはLPSおよびATPのいずれも添加せず、対照群2にはATPのみ添加し、対照群3にはLPSのみ添加し、対照群4にはLPSおよびATPを添加した。ATP添加から1時間後に上清を回収した。上清中に含まれるインターロイキン−1β(本明細書において、「IL−1β」ということがある)量は、ELISA法によってMouse IL-1 beta ELISA Ready-SET-Go!(商標名) Kit(eBioscience社製)を用いて測定した。上清中に含まれるインターロイキン−18(本明細書において、「IL−18」ということがある)量はELISA法によって、Mouse IL-18 ELISA KIT(MBL社製)を用いて測定した。なお、LPSとATPの両方をマクロファージに作用させることにより、マクロファージ細胞内においてインフラマソームが活性化され、炎症性サイトカインであるIL−1βおよびIL−18が産生される(Yuan He et al., Trends Biochem Sci. 41(12):1012-1021(2016))。
結果は、図1および図2に示される通りであった。
(1)試験方法
ア 群分け
5週齢の雄C57BL/6Jマウス(チャールズリバー社)を1週間馴化飼育した。馴化後のマウスを体重に偏りがないように4群に分け、標準食を摂取させる群を「標準食群」(6匹)とし、乳酸菌入りの標準食を摂取させる群を「標準食乳酸菌群」(6匹)とし、高脂肪食を摂取させる群を「高脂肪食群」(15匹)とし、乳酸菌入りの高脂肪食を摂取させる群を「高脂肪食乳酸菌群」(15匹)とし、試験を開始した。試験期間中は、温度25±1℃、湿度60±15%、明暗周期12時間に保たれた室内で1ケージあたり3匹のマウスを飼育した。また、体重は1週間に1回測定し、各群の平均体重を算出した。
試験開始とともに、被験飼料として、標準食群および標準食乳酸菌群にはD12450(ResearchDiets社製)を自由摂取させ、高脂肪食群および高脂肪食乳酸菌群には脂肪含有量60kcal%の高脂肪飼料であるD12492(ResearchDiets社製)を自由摂取させた。標準食乳酸菌群および高脂肪食乳酸菌群にはKW3110株の加熱死菌体を1mg/日/匹となるように上記の各飼料とともに混餌摂取させた。被験飼料を16週間摂取させた後、グルコース負荷試験を実施した。次いで、被験飼料をグルコース負荷試験後1週間摂取させた後、インスリン抵抗性試験を実施した。
被験飼料を16週間摂取させた後、マウスを16時間絶食させた。絶食後、生理食塩水で調製したグルコース溶液をマウス当たり1g/kg体重となるように腹腔内投与した。グルコース溶液投与から0、15、30、60、120分後に尾静脈から採血し、回収した血液中の血糖値(血中グルコース濃度)をグルテストNeoセンサー(三和化学研究所社製)を用いて測定した。測定した血糖値に基づいて血中グルコース濃度時間曲線下面積(グルコースAUC)を算出した。高脂肪食群および高脂肪食乳酸菌群における血糖値および血中グルコース濃度時間曲線下面積の群間差の検定はt検定により行い、統計学的な有意水準は5%とした。
グルコース負荷試験から1週間後に、マウスを6時間絶食させた。絶食後、生理食塩水で調製したインスリン(Sigma社製)をマウス当たり1U/kg体重となるように腹腔内投与した。インスリン投与から0、30、60、120分後に尾静脈から採血し、回収した血液中の血糖値(血中グルコース濃度)をグルテストNeoセンサー(三和化学研究所社製)を用いて測定した。測定した血糖値に基づいて血中グルコース濃度時間曲線下面積(グルコースAUC)を算出した。高脂肪食群および高脂肪食乳酸菌群における血糖値および血中グルコース濃度時間曲線下面積の群間差の検定はt検定により行い、統計学的な有意水準は5%とした。
結果は、図3〜7に示される通りであった。
Claims (8)
- ラクトバチルス・パラカゼイ菌体および/またはその処理物を有効成分として含んでなる、糖代謝異常の予防または改善用組成物。
- 糖代謝異常が、空腹時高血糖、随時高血糖および食後高血糖からなる群から選択される高血糖状態である、請求項1に記載の組成物。
- 糖代謝異常が、耐糖能異常である、請求項1に記載の組成物。
- 糖代謝異常が、インスリン抵抗性である、請求項1に記載の組成物。
- 糖代謝異常が、インフラマソームの活性化に起因するものである、請求項1〜4のいずれか一項に記載の組成物。
- ラクトバチルス・パラカゼイ菌体および/またはその処理物を有効成分として含んでなる、血糖値上昇の抑制用組成物。
- 食品組成物である、請求項1〜6のいずれか一項に記載の組成物。
- ラクトバチルス・パラカゼイが、KW3110菌株(FERM BP−08634)である、請求項1〜7のいずれか一項に記載の組成物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018082025A JP7206623B2 (ja) | 2018-04-23 | 2018-04-23 | 糖代謝異常の予防および改善用組成物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018082025A JP7206623B2 (ja) | 2018-04-23 | 2018-04-23 | 糖代謝異常の予防および改善用組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019187264A true JP2019187264A (ja) | 2019-10-31 |
JP7206623B2 JP7206623B2 (ja) | 2023-01-18 |
Family
ID=68387523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018082025A Active JP7206623B2 (ja) | 2018-04-23 | 2018-04-23 | 糖代謝異常の予防および改善用組成物 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7206623B2 (ja) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009102276A (ja) * | 2007-10-25 | 2009-05-14 | Tsujido Kagaku Kk | 抗糖尿病剤 |
WO2015146916A1 (ja) * | 2014-03-24 | 2015-10-01 | 大塚製薬株式会社 | 新規ラクトバチラス・パラカゼイ株 |
-
2018
- 2018-04-23 JP JP2018082025A patent/JP7206623B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009102276A (ja) * | 2007-10-25 | 2009-05-14 | Tsujido Kagaku Kk | 抗糖尿病剤 |
WO2015146916A1 (ja) * | 2014-03-24 | 2015-10-01 | 大塚製薬株式会社 | 新規ラクトバチラス・パラカゼイ株 |
Non-Patent Citations (5)
Title |
---|
EUR. FOOD RES. TECHNOL., 2012年, vol. 234, JPN6021037889, pages 627 - 638, ISSN: 0004772867 * |
ITAL. J. FOOD SCI., 2002年, vol. 14, no. 4, JPN6021037888, pages 351 - 362, ISSN: 0004772866 * |
JOURNAL OF FUNCTIONAL FOODS, 2016年, vol. 24, JPN6021037886, pages 472 - 481, ISSN: 0004772864 * |
JOURNAL OF NUTRITION AND METABOLISM, 2016年, vol. Volume 2016, Article ID 5190846, JPN6021037887, pages 1 - 8, ISSN: 0004772865 * |
PLOS ONE, 2013年, vol. Vol.8, Issue7, JPN6021037890, pages 68731 - 1, ISSN: 0004772868 * |
Also Published As
Publication number | Publication date |
---|---|
JP7206623B2 (ja) | 2023-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI784953B (zh) | 短雙岐桿菌及/或含有其培養物之用途 | |
JP7280069B2 (ja) | 機能性消化管障害予防又は改善用組成物、並びに、該機能性消化管障害予防又は改善用組成物を用いた医薬品組成物及び飲食品組成物 | |
KR20080059581A (ko) | 장내 플로라 개선용 조성물 | |
AU2019241546B2 (en) | Sleep-promoting composition, and medicinal composition and food and beverage composition using said sleep-promoting composition | |
KR101545551B1 (ko) | 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물 | |
JP6773368B2 (ja) | 免疫発達促進剤 | |
WO2021015107A1 (ja) | 組成物 | |
US11730171B2 (en) | Composition for enhancing breast milk component | |
US11638431B2 (en) | Fermented milk and polysaccharide with cancerous cachexia inhibitory effect | |
JP7041508B2 (ja) | 概日リズム改善用組成物 | |
KR20200070081A (ko) | 충치 억제 활성을 갖는 락토바실러스 살리바리우스를 포함하는 조성물 | |
WO2019188943A1 (ja) | 脳血流低下の予防及び/又は改善用組成物 | |
JP4787159B2 (ja) | 抗ストレス剤 | |
JP7049397B2 (ja) | 抑うつの抑制または改善用組成物 | |
JP5238373B2 (ja) | 腸間膜脂肪低減剤 | |
JP7206623B2 (ja) | 糖代謝異常の予防および改善用組成物 | |
JP7158884B2 (ja) | 炎症抑制用組成物 | |
JP6976030B2 (ja) | 非アルコール性脂肪肝疾患の予防または改善用組成物 | |
KR20200070080A (ko) | 충치 억제 활성을 갖는 락토바실러스 루테리 mg505 를 포함하는 조성물 | |
JP2021023257A (ja) | 分離不安障害の予防又は改善のための組成物 | |
KR102536139B1 (ko) | 락토바실러스 브레비스 ku15147을 포함하는 관절염 예방 또는 치료용 조성물 | |
JP7408070B2 (ja) | ビフィドバクテリウム・ビフィダムを含む免疫力増強または改善用組成物 | |
EP4342535A1 (en) | Composition for inhibition of differentiation of osteoclast precursor cells into osteoclasts, and composition for improving bone metabolism | |
KR102244732B1 (ko) | 프로바이오틱 초산균인 아세토박터 파스테리아누스 mglv 및 이의 면역조절 효과 | |
TWI837785B (zh) | 含有短雙岐桿菌之培養物之用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20190731 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190828 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20201118 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210922 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211005 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20211129 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220131 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220517 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220613 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220915 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221206 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221219 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7206623 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |